• 1
    Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish 2-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992;30:187-210.
  • 2
    Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:954-958.
  • 3
    Anttila A, Sarkeala T, Hakulinen T, Heinavaara S. Impacts of the Finnish service screening programme on breast cancer rates [serial online]. BMC Public Health. 2008;8:38.
  • 4
    McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen. 1998;5:42-48.
  • 5
    Schouten LJ, de Rijke JM, Schlangen JT, Verbeek AL. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands. J Med Screen. 1998;5:37-41.
  • 6
    Schouten LJ, de Rijke JM, Huveneers JA, Verbeek AL. Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme. J Med Screen. 2002;9:120-124.
  • 7
    Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer. 2004;91:861-867.
  • 8
    Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer. 1999;81:877-880.
  • 9
    Hofvind S, Sorum R, Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol. 2008;47:225-231.
  • 10
    Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in the Netherlands: a population based study [serial online]. Breast Cancer Res. 2012;14:R10.
  • 11
    Verkooijen HM, Fioretta G, Vlastos G, et al. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland Int J Cancer. 2003;104:778-781.
  • 12
    Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control. 1999;10:333-337.
  • 13
    Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control. 2004;11:222-230.
  • 14
    Escobedo LG, Zhong Z, Key C. Breast and cervical cancer screening and disease incidence and stage in New Mexico. Cancer Causes Control. 2002;13:137-145.
  • 15
    Zappa M, Dardanoni G, Giorgi Rossi P, et al. The diffusion of screening programmes in Italy, year 2009. Epidemiol Prev. 2011;35(suppl 5):1-96.
  • 16
    Paci E, Miccinesi G, Puliti D, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time: a service screening study in Italy [serial online]. Breast Cancer Res. 2006;8:R68.
  • 17
    Zorzi M, Puliti D, Vettorazzi M, et al. Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001). Br J Cancer. 2006;95:1265-1268.
  • 18
    Puliti D, Miccinesi G, Collina N, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer. 2008;99:423-427.
  • 19
    Anttila A, Laara E. Cervix cancer: geographical correlations. In: Sankila R, Demaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM, eds. Evaluation and Monitoring of Screening Programmes. Luxembourg: Office for Official Publications of the European Communities; 2001:77-98.
  • 20
    Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer. 2005;117:842-847.
  • 21
    Layeequr Rahman R, Siegel E, Boneti C, et al. Stage migration with sentinel node biopsy in breast cancer. Am J Surg. 2009;197:491-496.
  • 22
    Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, Nieuwenhuijzen GA. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat. 2009;113:173-179.
  • 23
    Broeders M, Nystrom L, Ascunce N, et al. Epidemiological guidelines for quality assurance in breast cancer screening. In: Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L, eds. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006:15-56.
  • 24
    Bucchi L, Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts. J Med Screen. 2008;15:30-35.
  • 25
    Autier P, Boniol M, Middleton R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol. 2011;22:1726-1735.